RSS-Feed abonnieren
DOI: 10.1055/a-2600-7069
Postpartum Hemorrhage Morbidity in Deliveries Complicated by Elevated Body Mass Index
Autor*innen
Funding None.
Abstract
Objective
The relationship between body mass index (BMI) ≥ 30 in pregnancy and postpartum hemorrhage (PPH) has been unclear. While some risk stratification protocols classify elevated BMI as a moderate risk factor others do not. This study aimed to examine the effect of elevated BMI on PPH in a contemporary population.
Study Design
This retrospective cohort study included all singletons ≥14 weeks with recorded BMI who delivered at a Level IV center for two consecutive years. The exposure group was sub-categorized into BMI of 30 to 39.9 and BMI ≥ 40 kg/m2, with a planned subgroup by mode of delivery. Data was collected by clinicians, and the composite maternal hemorrhagic outcome (CMHO) was defined as: blood loss ≥ 1,000 mL, interventions for atony including use of uterotonics (excluding prophylactic oxytocin), mechanical tamponade, surgical intervention, venous thromboembolism, admission to the intensive care unit, hysterectomy, or maternal death. Adjusted relative risks (aRR) with 95% confidence intervals (CI) were calculated using multivariate Poisson regression with robust error variance.
Results
Of 8,623 deliveries in the study period, 8,340 (96.7%) met inclusion criteria, with 2,943 (35%) with BMI < 30.0, 3,900 (46%) with BMI of 30 to 39.9 kg/m2, and 1,497 (17%) with BMI of ≥40 kg/m2. CHMO was increased for BMI of 30 to 39.9 (aRR: 1.16; 95% CI: 1.04–1.29) and ≥40.0 (aRR: 1.19; 95% CI: 1.04–1.36), largely due to increased risk of blood loss ≥ 1,000 and uterotonic use. A subgroup analysis by mode of delivery noted that increased risk for CHMO was only present in BMI ≥ 40 for vaginal deliveries (aRR: 1.35; 95% CI: 1.10–1.65) and only for BMI of 30 to 39.9 in cesarean delivery (aRR: 1.28; 95% CI: 1.10–1.50).
Conclusion
Parturients with BMI ≥ 30 had a higher risk of hemorrhage-related morbidity compared with patients with BMI < 30, however, clinical management and impact need further investigation.
Key Points
-
Patients with an elevated BMI had a higher risk of hemorrhage-related morbidity.
-
Individuals with BMI ≥ 40 kg/m2 are at increased risk of hemorrhage with vaginal deliveries.
-
With rising BMI rates, research on perinatal risks and targeted interventions is crucial for better.
Publikationsverlauf
Eingereicht: 01. April 2025
Angenommen: 05. Mai 2025
Accepted Manuscript online:
07. Mai 2025
Artikel online veröffentlicht:
10. Juni 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Driscoll A, Gregory E. “Increases in prepregnancy obesity: United States, 2016–2019.,” NCHS Data Brief No 392, vol. National Center for Health Statistics., 2020.
- 2 Obesity in pregnancy: ACOG practice bulletin, number 230. Obstet Gynecol 2021; 137 (06) e128-e144
- 3 Say L, Chou D, Gemmill A. et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health 2014; 2 (06) e323-e333
- 4 Lagrew D, McNulty J, Sakowisk C, Cape V, McCormick E, Morton C. “Improving Health Care Response to Obstetric Hemorrhage, a California Maternal Quality Care Collaborative Toolkit, 2022.,” 2022.
- 5 Committee on Practice Bulletins-Obstetrics. Practice bulletin no. 183: postpartum hemorrhage. Obstet Gynecol 2017; 130 (04) e168-e186
- 6 Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN)., “Postpartum Hemorrhage Project: A Multi-Hospital Quality Improvement Program,” 2017.
- 7 Ghose I, Wiley RL, Ciomperlik HN. et al. Association of adverse outcomes with three-tiered risk assessment tool for obstetrical hemorrhage. Am J Obstet Gynecol MFM 2023; 5 (10) 101106
- 8 Cagino KA, Wiley RL, Ghose I. et al. Risk of postpartum hemorrhage in hypertensive disorders of pregnancy: stratified by severity. Am J Perinatol 2024; 41 (15) 2165-2174
- 9 Schwartzenburg C, Wiley RL, Ghose I, Ciomperlik HN, Chauhan SP, Mendez-Figueroa H. Postpartum hemorrhage risk stratification: association of adverse outcomes with and without documentation. Am J Obstet Gynecol MFM 2024; 6 (04) 101262
- 10 von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. STROBE Initiative. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007; 335 (7624): 806-808
- 11 Gollop ND, Childs CA, Coupe B, MacFarlane S, Burrell J, Kumar B. Body weight, body image and primary postpartum haemorrhage: a review of the literature. J Obstet Gynaecol 2014; 34 (05) 373-382
- 12 Durmaz A, Komurcu N. Relationship between maternal characteristics and postpartum hemorrhage: a meta-analysis study. J Nurs Res 2018; 26 (05) 362-372
- 13 Sundjaja CD, Lee MY, Cheng C, Neuhoff BK, Munter BT, Byrne JJ. Incidence of severe maternal morbidity in obese patients with postpartum hemorrhage. Am J Obstet Gynecol 2023; 228 (01) S278-S279
- 14 Butwick AJ, Abreo A, Bateman BT. et al. Effect of maternal body mass index on postpartum hemorrhage. Anesthesiology 2018; 128 (04) 774-783
- 15 Blomberg M. Maternal obesity and risk of postpartum hemorrhage. Obstet Gynecol 2011; 118 (03) 561-568
- 16 Whitley J, Dazelle W, Kripalani S, Ahmadzia H. The association between body mass index and postpartum hemorrhage after cesarean delivery. Sci Rep 2023; 13 (01) 11998
- 17 Peska E, Balki M, Maxwell C, Ye XY, Downey K, Carvalho JCA. Oxytocin at elective caesarean delivery: a dose-finding study in women with obesity. Anaesthesia 2021; 76 (07) 918-923
- 18 Roloff K, Peng S, Sanchez-Ramos L, Valenzuela GJ. Cumulative oxytocin dose during induction of labor according to maternal body mass index. Int J Gynaecol Obstet 2015; 131 (01) 54-58
- 19 Caughey AB, Cahill AG, Guise J-M, Rouse DJ. American College of Obstetricians and Gynecologists (College), Society for Maternal-Fetal Medicine. Safe prevention of the primary cesarean delivery. Am J Obstet Gynecol 2014; 210 (03) 179-193
